Selected research
Market Structure
Global Vitamin K1 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vitamin K1 Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vitamin K1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vitamin K1 Injection include Suicheng Pharmaceutical, Jiangsu Huayang Pharmaceutical, Cheng Yi Pharmaceutical, Brilliant Pharmaceutical, Wuhu Kangqi Pharmaceuticals, Innopharma and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vitamin K1 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vitamin K1 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vitamin K1 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin K1 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Vitamin K1 Injection Segment by Company
Suicheng Pharmaceutical
Jiangsu Huayang Pharmaceutical
Cheng Yi Pharmaceutical
Brilliant Pharmaceutical
Wuhu Kangqi Pharmaceuticals
Innopharma
AdvaCare
Vitamin K1 Injection Segment by Type
2mg/mL
5mg/mL
10mg/mL
Vitamin K1 Injection Segment by Application
Hospital
Clinic
Others
Vitamin K1 Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin K1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin K1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin K1 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vitamin K1 Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vitamin K1 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vitamin K1 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vitamin K1 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2mg/mL
- 5mg/mL
- 10mg/mL
Applications
- Hospital
- Clinic
- Others
Companies covered
- Suicheng Pharmaceutical
- Jiangsu Huayang Pharmaceutical
- Cheng Yi Pharmaceutical
- Brilliant Pharmaceutical
- Wuhu Kangqi Pharmaceuticals
- Innopharma
- AdvaCare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vitamin K1 Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vitamin K1 Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vitamin K1 Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vitamin K1 Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vitamin K1 Injection Market Dynamics
- 2.1 Vitamin K1 Injection Industry Trends
- 2.2 Vitamin K1 Injection Industry Drivers
- 2.3 Vitamin K1 Injection Industry Opportunities and Challenges
- 2.4 Vitamin K1 Injection Industry Restraints
3 Vitamin K1 Injection Market by Manufacturers
- 3.1 Global Vitamin K1 Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Vitamin K1 Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Vitamin K1 Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vitamin K1 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vitamin K1 Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vitamin K1 Injection Manufacturers, Product Type & Application
- 3.7 Global Vitamin K1 Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vitamin K1 Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vitamin K1 Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Vitamin K1 Injection Tier 1, Tier 2, and Tier 3
4 Vitamin K1 Injection Market by Type
- 4.1 Vitamin K1 Injection Type Introduction
- 4.1.1 2mg/mL
- 4.1.2 5mg/mL
- 4.1.3 10mg/mL
- 4.2 Global Vitamin K1 Injection Sales by Type
- 4.2.1 Global Vitamin K1 Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vitamin K1 Injection Sales by Type (2021-2032)
- 4.2.3 Global Vitamin K1 Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Vitamin K1 Injection Revenue by Type
- 4.3.1 Global Vitamin K1 Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vitamin K1 Injection Revenue by Type (2021-2032)
- 4.3.3 Global Vitamin K1 Injection Revenue Market Share by Type (2021-2032)
5 Vitamin K1 Injection Market by Application
- 5.1 Vitamin K1 Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Vitamin K1 Injection Sales by Application
- 5.2.1 Global Vitamin K1 Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamin K1 Injection Sales by Application (2021-2032)
- 5.2.3 Global Vitamin K1 Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Vitamin K1 Injection Revenue by Application
- 5.3.1 Global Vitamin K1 Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vitamin K1 Injection Revenue by Application (2021-2032)
- 5.3.3 Global Vitamin K1 Injection Revenue Market Share by Application (2021-2032)
6 Global Vitamin K1 Injection Sales by Region
- 6.1 Global Vitamin K1 Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vitamin K1 Injection Sales by Region (2021-2032)
- 6.2.1 Global Vitamin K1 Injection Sales by Region (2021-2026)
- 6.2.2 Global Vitamin K1 Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vitamin K1 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vitamin K1 Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vitamin K1 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vitamin K1 Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vitamin K1 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vitamin K1 Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vitamin K1 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vitamin K1 Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vitamin K1 Injection Revenue by Region
- 7.1 Global Vitamin K1 Injection Revenue by Region
- 7.1.1 Global Vitamin K1 Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vitamin K1 Injection Revenue by Region (2021-2026)
- 7.1.3 Global Vitamin K1 Injection Revenue by Region (2027-2032)
- 7.1.4 Global Vitamin K1 Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vitamin K1 Injection Revenue (2021-2032)
- 7.2.2 North America Vitamin K1 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vitamin K1 Injection Revenue (2021-2032)
- 7.3.2 Europe Vitamin K1 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vitamin K1 Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vitamin K1 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vitamin K1 Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vitamin K1 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Suicheng Pharmaceutical
- 8.1.1 Suicheng Pharmaceutical Company Information
- 8.1.2 Suicheng Pharmaceutical Business Overview
- 8.1.3 Suicheng Pharmaceutical Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Suicheng Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.1.5 Suicheng Pharmaceutical Recent Developments
- 8.2 Jiangsu Huayang Pharmaceutical
- 8.2.1 Jiangsu Huayang Pharmaceutical Company Information
- 8.2.2 Jiangsu Huayang Pharmaceutical Business Overview
- 8.2.3 Jiangsu Huayang Pharmaceutical Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Huayang Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.2.5 Jiangsu Huayang Pharmaceutical Recent Developments
- 8.3 Cheng Yi Pharmaceutical
- 8.3.1 Cheng Yi Pharmaceutical Company Information
- 8.3.2 Cheng Yi Pharmaceutical Business Overview
- 8.3.3 Cheng Yi Pharmaceutical Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cheng Yi Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.3.5 Cheng Yi Pharmaceutical Recent Developments
- 8.4 Brilliant Pharmaceutical
- 8.4.1 Brilliant Pharmaceutical Company Information
- 8.4.2 Brilliant Pharmaceutical Business Overview
- 8.4.3 Brilliant Pharmaceutical Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Brilliant Pharmaceutical Vitamin K1 Injection Product Portfolio
- 8.4.5 Brilliant Pharmaceutical Recent Developments
- 8.5 Wuhu Kangqi Pharmaceuticals
- 8.5.1 Wuhu Kangqi Pharmaceuticals Company Information
- 8.5.2 Wuhu Kangqi Pharmaceuticals Business Overview
- 8.5.3 Wuhu Kangqi Pharmaceuticals Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Wuhu Kangqi Pharmaceuticals Vitamin K1 Injection Product Portfolio
- 8.5.5 Wuhu Kangqi Pharmaceuticals Recent Developments
- 8.6 Innopharma
- 8.6.1 Innopharma Company Information
- 8.6.2 Innopharma Business Overview
- 8.6.3 Innopharma Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Innopharma Vitamin K1 Injection Product Portfolio
- 8.6.5 Innopharma Recent Developments
- 8.7 AdvaCare
- 8.7.1 AdvaCare Company Information
- 8.7.2 AdvaCare Business Overview
- 8.7.3 AdvaCare Vitamin K1 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AdvaCare Vitamin K1 Injection Product Portfolio
- 8.7.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vitamin K1 Injection Value Chain Analysis
- 9.1.1 Vitamin K1 Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vitamin K1 Injection Production Mode & Process
- 9.2 Vitamin K1 Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vitamin K1 Injection Distributors
- 9.2.3 Vitamin K1 Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst